Pharmaceutical Product Development is looking to sell – and a potential deal could value the Wilmington-based contract research organization at $5 billion, the Wall Street Journal reports.
Citing “people familiar with the matter,” WSJ says PPD is looking for a buyer with help from Goldman Sachs Group Inc., J.P. Morgan Chase & Co., and Centerview Partners. The deal could be as close as the first quarter of next year, according to the report.
In 2011, PPD was taken private by Carlyle Group…
Pharmaceutical Product Development is looking to sell – and a potential deal could value the Wilmington-based contract research organization at $5 billion, the Wall Street Journal reports.
Citing “people familiar with the matter,” WSJ says PPD is looking for a buyer with help from Goldman Sachs Group Inc., J.P. Morgan Chase & Co., and Centerview Partners. The deal could be as close as the first quarter of next year, according to the report.
In 2011, PPD was taken private by Carlyle Group…